These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17636407)

  • 21. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
    Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X
    Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
    Ali A; Shah AS; Ahmad A
    Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescence.
    Joruiz SM; Von Muhlinen N; Horikawa I; Gilbert MR; Harris CC
    Cell Death Dis; 2024 Jun; 15(6):454. PubMed ID: 38937431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer: Does Null Pattern Correlate With Prognosis?
    Sakamoto I; Kagami K; Nozaki T; Hirotsu Y; Amemiya K; Oyama T; Omata M
    Am J Surg Pathol; 2023 Oct; 47(10):1144-1150. PubMed ID: 37528644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
    Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
    Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer.
    Zhao Y; Yamashita T; Ishikawa M
    Oncol Rep; 2005 Apr; 13(4):721-6. PubMed ID: 15756448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
    Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
    Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1.
    Lv T; Lv H; Fei J; Xie Y; Lian D; Hu J; Tang L; Shi X; Wang J; Zhang S; Li F; Jiang X; Yi Y
    J Cancer; 2020; 11(23):6874-6882. PubMed ID: 33123278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).
    Tan BS; Tiong KH; Choo HL; Chung FF; Hii LW; Tan SH; Yap IK; Pani S; Khor NT; Wong SF; Rosli R; Cheong SK; Leong CO
    Cell Death Dis; 2015 Jul; 6(7):e1826. PubMed ID: 26181206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant-negative p53 mutations in rheumatoid arthritis.
    Han Z; Boyle DL; Shi Y; Green DR; Firestein GS
    Arthritis Rheum; 1999 Jun; 42(6):1088-92. PubMed ID: 10366100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
    Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
    J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3.
    Feng Y; Qian R; Cui D; Luan J; Xu M; Wang L; Li R; Wu X; Chang C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):312. PubMed ID: 38900156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancers.
    Sherbet GV; Patil D
    Anticancer Res; 2003; 23(2B):1357-71. PubMed ID: 12820395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.